Summary

Overview
Global Thoracic Drainage Devices Market reached US$ YY billion in 2022 and is expected to reach US$ YY billion by 2030 growing with a CAGR of YY% during the forecast period 2023-2030. The trend such as the shift towards minimal invasive thoracic drainage procedures driven by patient preference for less invasive techniques is expected to dominate the global thoracic drainage devices market.
The global thoracic drainage devices market has grown significantly in recent years and is projected to continue on its upward trend. The market is undergoing a transformational period, influenced by several significant trends such as digitalization in chest drainage systems equipped with connectivity features allowing real-time monitoring of patients, remote data access, and improved patient management.
Furthermore, the rising prevalence of thoracic diseases, Continuous technological advancements in thoracic drainage devices have improved their efficiency and safety and increasing number of thoracic surgeries, including lung resections and transplantations, that requires thoracic drainage devices for post-operative care are driving up the thoracic drainage devices market size. The growing research activities for new technologies and presence of establish pharmaceutical medtech companies are some of the factors in demand from North American regions. With significant competitors like ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, and others actively operating in the market.
Dynamics
The Increasing Number of Thoracic Surgeries to Drive the Growth of the Thoracic Drainage Devices Market
The increasing number of thoracic surgeries is an important factor driving in the market for thoracic drainage devices. These devices are essential in cardiothoracic surgery because they allow for the drainage of blood, fluids, and air from the pericardial and pleural cavities, reducing post-operative problems and minimizing concerns such as effusions, tamponade, pneumothoraces, and hemorrhage. Prior to the development of improved digital drainage devices, the classic 3-chamber suction technique was the standard in thoracic surgery for the past five decades.
For instance, according to a National Library of Medicine article published in 2022, states that about 530,000 general thoracic surgery cases are performed annually in the U.S alone by approximately 4,000 cardiothoracic surgeons, the majority of them are male (92%), with an average age of 56 years. The average thoracic surgeon performs 135 patients per year. This increase in thoracic procedures emphasizes the market's potential for growth in enhancing patient care and outcomes.
The Advancements in Technologies will Drive the Thoracic Drainage Devices Market Growth
The growing advancements in thoracic drainage devices emcompassing advanced design is expected to drive the market. For instance, in September 2023, Merit Medical Systems, Inc. announced the launch of its Aspira Evacuated Drainage Bottle. The Aspira Drainage System is used to treat recurring and symptomatic pleural effusions (fluid buildup outside the lungs) and malignant ascites (fluid buildup in the abdomen caused by cancer).
Furthermore, the indications for the Aspira Drainage System for draining recurrent pleural effusions and malignant ascites, both of which frequently require in-hospital drainage, show the crucial role of cutting-edge drainage technologies in improving patient care and quality of life. Thus, as more healthcare organizations and professionals adopt cutting-edge solutions, the market for thoracic drainage devices is expected to grow, fueled by technological improvements that improve efficiency, precision, and patient outcomes over the forecast period.
The Lack of Availability of Skilled Professional Will Hamper the Growth of the Market.
The lack of availability of skilled professional is the major restraint for this market. Thoracic drainage is an advanced surgical procedure that requires interdisciplinary collaboration, and nurses play a significant role in chest tube insertion and care. However, chest tubes inserted by resident physicians are frequently associated with problems, emphasizing the need for further training.
Furthermore, chest tube insertion is a common procedure performed by radiologists, pulmonary specialists, and thoracic surgeons. According to the Radiological Society of North America 2022 article, there is a shortage of radiologists in the U.K, since Europe has 13 radiologists per 100,000 people, but the rate in the U.K. is only 8.5 per 100,000. Thus, owing to this factor the market is expected to grow over the forecast period.
Segment Analysis
The global thoracic drainage devices market is segmented based on product, material type, application, end user and region.
Owing to the Better Effectiveness and Variety, the Chest Drainage Systems Segment Accounted for Approximately 47.2% of the Thoracic Drainage Devices Market Share
The chest drainage systems segment is expected to dominate the thoracic drainage device market. These systems are widely used in a variety of clinical settings, including cardiac surgery, cardiothoracic surgery, pulmonology, and critical care, to treat diseases such as pleural effusion, pneumothorax, hemothorax, and post-operative drainage.
This segment's is dominated due to the variety and effectiveness of chest drainage devices in removing air and fluids from the pleural area, hence aiding lung re-expansion and reducing problems. Furthermore, contemporary technological advancements in digital chest drainage systems, which allow for real-time monitoring and enhanced patient management, contribute to their widespread acceptability.
For instance, in July 2022, Centese, Inc. announced the first peer-reviewed study for its Thoraguard digital drainage system for cardiac surgery at Stanford University Medical Center, which was published in the Journal of Thoracic and Cardiovascular Surgery Open. Thoraguard is the first and only digital chest tube management system that delivers automated clog removal without human intervention while continuously and precisely monitoring vital physiological indicators to support clinical decision-making and enhance outcomes. Furthermore, when utilized during heart surgery, Thoraguard was demonstrated to be safe and efficacious when compared to standard analog chest tubes. Thus, owing to the above factors the segment is expected to dominate over the forecast period.
Geographical Penetration
North America Accounted for Approximately 38.2% of the Market Share in 2022, Owing to the Increasing Number of Clinical Trials
The increasing number of clinical trials in North America is expected to dominate the thoracic drainage device market. Clinical trials play a vital role in determining the safety and efficacy of novel devices. For instance, the University of Oklahoma is conducting a clinical trial comparing the Digital Chest Tube Drainage System (Thopaz+) to the Analog in Pediatric Patients." The purpose of the research is to assess the efficacy of digital (Thopaz+) and analog (Pleur-evac) drainage devices in pediatric patients. The trial is an interventional, randomized, and controlled study that is expected to enroll 140 people.
Furthermore, the study is expected to be finished by April 1, 2024 and there have been no prospective randomized controlled trials comparing digital versus analog chest tube drainage systems in pediatric patients so far. This will be the first prospective randomized trial to look into the possible benefits of adopting a digital chest tube drainage system in pediatric patients.
Moreover, the increasing prevalence of chronic diseases in North America is also expected to drive the market. Chronic diseases such as heart disease and pulmonology disease are significant drivers of demand for thoracic drainage devices. As the population ages and lifestyle factors increase the prevalence of chronic diseases, the need for appropriate thoracic drainage treatments grows. Thus, owing to the above factors the region is expected to dominate over the forecast period.
Competitive Landscape
The major global players in the thoracic drainage devices market include ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, Cardinal Health., Cook Group Incorporated, Getinge AB, Sinapi Biomedical, Teleflex Incorporated, Utah Medical Products, Inc., Vygon SA, Sterimed Group, and among others.
COVID-19 Impact Analysis

The World Health Organization (WHO) reported more roughly 585.0 million confirmed COVID-19 cases as of August 2022, with around 6.4 million recorded deaths. However, research has shown that thoracic drainage systems play an important role in preventing the widespread development of COVID-19. Individuals with COVID-19 are at a higher risk of having acute respiratory distress syndrome (ARDS), which requires invasive mechanical ventilation.
Furthermore, COVID-19-related barotrauma frequently results in pneumothorax, necessitating chest tube insertion (thoracostomy). Furthermore, members of the German Health Alliance (GHA), which include prominent companies such as B. Braun, ATMOS MedizinTechnik GmbH & Co. KG, Getinge, and Dräger, have seen a significant increase in global demand for their products, particularly thoracic drainage systems, since the beginning of 2020. ATMOS MedizinTechnik GmbH & Co. KG, for example, an innovative medical device maker, has increased production to meet increased demand, realizing that product categories such as drainage systems play a critical role in saving lives in the face of the COVID-19 epidemic.
Key Developments
• On April 18, 2022, Merit Medical Systems, Inc., a global leader in the manufacture and marketing of healthcare technologies, stated the launch of the ReSolve Thoracostomy Tray. The new tray includes everything needed to execute a thoracostomy, a minimally invasive method that allows patients to avoid open surgery to drain fluids or air from the chest.
• On December 15, 2020, Medela LLC stated that their Thopaz+ Digital Chest Drainage and Monitoring System completed various quantitative tests demonstrating that its filtration system efficiently inhibits the passage of aerosolized viral particles such as SARS-CoV-2, the virus responsible for COVID-19.
Why Purchase the Report?
• To visualize the global thoracic drainage devices market segmentation based on product, material type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of thoracic drainage devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.
The global thoracic drainage devices market report would provide approximately 53 tables, 54 figures and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Material Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing Number of Thoracic Surgeries
4.1.1.2. The Advancements in Technologies
4.1.2. Restraints
4.1.2.1. The Lack of Availability of Skilled Professional
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Chest Drainage Systems*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.2.1. Water Seal Chest Drainage Systems
7.2.2.2. Dry Seal Chest Drainage Systems
7.2.2.3. Digital Chest Drainage Systems
7.3. Thoracic Drainage Kits
7.4. Pleural Drainage Catheters
7.4.1. Thoracentesis Catheters
7.4.2. Paracentesis Catheters
7.4.3. Others
7.5. Trocar Drains
7.6. Others
8. By Material Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.1.2. Market Attractiveness Index, By Material Type
8.2. Silicone*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Polyurethane
8.4. Latex
8.5. Other
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Cardiac Surgery*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Oncology & Pain Management
9.4. Thoracic Surgery & Pulmonology
9.5. General Intensive Care Emergency Medicine
9.6. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgery Centers
10.4. Cardiac Specialty Clinics
10.5. Cardiothoracic Centers
10.6. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Spain
11.3.7.5. Italy
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. ATMOS MedizinTechnik GmbH & Co. K*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Becton, Dickinson and Company
13.3. Cardinal Health.
13.4. Cook Group Incorporated
13.5. Getinge AB
13.6. Sinapi Biomedical
13.7. Teleflex Incorporated
13.8. Utah Medical Products, Inc.
13.9. Vygon SA
13.10. Sterimed Group
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us